Aim: The goal of this study was to investigate the combined effects of raloxifene and
atorvastatin in aged ovariectomized rats during endothelial dysfunction and atherosclerotic …

Aim Endothelial dysfunction is considered a premature indication of atherosclerosis and
vessel damage and is present in the postmenopausal period. This study compares the …

Background: Different hormonal replacement regimens are used for treating climacteric
complaints; however, not all of them have the same clinical profile. Cardiovascular disease …

Background: The role of hormone-replacement therapy in decreasing the risk of
cardiovascular disease in women has not been firmly established. Recent studies have …

Estrogen replacement therapy (ERT) is claimed to reduce cardiovascular mortality by about
50% in postmenopausal women. This improvement is caused by favorable changes in lipid …

Lack of an appropriate animal model has delayed the better understanding of mechanisms
related to higher cardiovascular risk in women after menopause. The aging female rat may …

During menopause, women have a higher propensity for developing cardiovascular
diseases. Recent studies have shown that treatment with selective estrogen receptor …

BACKGROUND:: After menopause women are more susceptible to coronary heart disease
due to increased risk of atherosclerosis. Tibolone (Livial) is an innovative synthetic steroid …

The present study investigated the effect of raloxifene, a selective estrogen receptor
modulator (SERM), on aortic atherosclerosis in 80 ovariectomized, cholesterol-fed rabbits …

Objectives: To determine the effects of estrogen and progestogen treatment on
atherosclerotic inflammation and vascular remodeling. Methods: Atherosclerosis was …